Abstract

Malaria and diabetes are two major health challenges in Nigeria, with malaria being a leading cause of morbidity 
and mortality, and diabetes rapidly emerging as a significant non-communicable disease. The coexistence of these 
two conditions presents a complex healthcare challenge, especially in malaria-endemic regions like Nigeria. This 
review explores the immunological interactions between malaria infection and diabetes, focusing on how diabetes 
influences the immune response, clinical progression, and outcomes of malaria. Diabetes, particularly when poorly 
managed, impairs immune function, increasing susceptibility to malaria and exacerbating its severity. Diabetic 
patients with malaria often experience prolonged illness, severe complications, and poorer clinical outcomes, such 
as cerebral malaria, organ failure, and hypoglycemia. Furthermore, the treatment of malaria in diabetic patients is 
complicated by potential drug interactions and the need for synchronized management of both diseases. This review 
highlights the importance of integrated care approaches, early detection, and the need for further research to better 
understand the dual burden of these diseases. Effective management strategies are essential to mitigate the health 
risks posed by the intersection of malaria and diabetes in Nigeria.